Atlas Trials

Plasmodium Immunotherapy for Lung Cancer

Clinical trial NCT02786589 · UNKNOWN

Trial details

NCT number
NCT02786589
Sponsor
State Key Laboratory of Respiratory Disease
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lung Cancer, Nonsmall Cell
Start date
2016-06-27
Primary completion
2020-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.